Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.cdtequity.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

ka1954 Aug. 19 at 11:22 AM

$CDT another fucking stock that recently did RS went up 1000% PFSA, just like VEEE, WETO, NVVE. come on CDT, do something

0 · Reply

Sam201 Aug. 18 at 3:25 PM

$CDT getting back below 3. Easy swings above n below 3s. but this is riskyy

0 · Reply

Nevilhch Aug. 18 at 1:44 PM

$CDT @Sam201 and @Bears2354 Alright, you assholes, I don't see you promoting anything .Did you blow your accounts already?

0 · Reply

Nevilhch Aug. 18 at 12:16 PM

$CDT very soon 🤑🤑🤑

0 · Reply

ka1954 Aug. 17 at 8:17 PM

$CDT they will fuck this stock badly in coming days. it always happens

0 · Reply

JimmyOcarri Aug. 17 at 7:49 PM

$ICCM $AIIO $CDT $RBNE $FABC goodness

0 · Reply

Pennytraderr1 Aug. 17 at 7:05 PM

🚨 $CDT — THIS SETUP IS WILD 👀🔥 💎 ~400K FLOAT (reported estimates) 💰 ~$2M MARKET CAP 🏦 ~$126.7M TOTAL ASSETS 📊 ~$103M STOCKHOLDERS’ EQUITY ⚛️ Sarborg quantum-computing exposure 🧬 Biotech + AI 🔥 NEW Sarborg patent developments 📅 Aug. 28 shareholder meeting = major near-term catalyst

0 · Reply

ka1954 Aug. 14 at 1:56 PM

$CDT they do up 1 day to lure more buyers. no volume

0 · Reply

BigGreenCandle Aug. 13 at 7:04 PM

$CDT Vapor thin float. Has to go sometime. Moon or bust.

1 · Reply

ka1954 Aug. 13 at 11:16 AM

$CDT with the OS count of 786k, this should be flying 200%+, what a turd

0 · Reply

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

Jul 20, 2026, 8:30 AM EDT - 4 weeks ago

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane

2026-07-17T23:55:15.000Z - 4 weeks ago

CDT Equity Inc trading halted, news pending

2026-07-16T12:15:47.000Z - 4 weeks ago

CDT Equity announces 1-for-10 reverse stock split

Jul 16, 2026, 8:00 AM EDT - 4 weeks ago

CDT Equity Inc. Announces Reverse Stock Split

Jun 26, 2026, 8:30 AM EDT - 7 weeks ago

CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development

2026-06-18T13:07:10.000Z - 2 months ago

CDT Equity notes investment into Sarborg, expansion into quantum computing

Jun 18, 2026, 8:30 AM EDT - 2 months ago

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Jun 16, 2026, 8:30 AM EDT - 2 months ago

CDT Equity Announces Debt Update and New Loan Facility

2026-05-28T20:47:21.000Z - 2 months ago

CDT Equity receives Nasdaq notice for delayed quarterly report

May 28, 2026, 4:15 PM EDT - 2 months ago

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

2026-05-27T14:17:57.000Z - 2 months ago

CDT Equity granted Canadian patent for AZD5904 in male infertility

AZN

May 27, 2026, 8:00 AM EDT - 3 months ago

CDT Announces Canadian Patent for AZD5904 in Male Infertility

May 7, 2026, 8:30 AM EDT - 3 months ago

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

2026-05-07T04:50:30.000Z - 3 months ago

CDT Equity announces AZD5904 progresses into patent cooperation treaty phase

AZN

May 6, 2026, 8:30 AM EDT - 3 months ago

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

2026-04-27T16:25:54.000Z - 4 months ago

CDT Equity management to meet with Maxim

2026-04-22T10:10:41.000Z - 4 months ago

CDT Equity files to sell 5.35M shares of common stock for holders

2026-04-20T17:25:11.000Z - 4 months ago

CDT Equity management to meet with Maxim

2026-04-16T12:47:10.000Z - 4 months ago

CDT Equity expands multi-pathway value creation strategy across pharma, IP

AZN

Apr 16, 2026, 8:30 AM EDT - 4 months ago

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

Apr 7, 2026, 8:30 AM EDT - 4 months ago

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

2026-03-27T13:45:58.000Z - 5 months ago

CDT Equity Inc trading resumes

2026-03-27T13:35:40.000Z - 5 months ago

CDT Equity Inc trading halted, volatility trading pause

2026-03-26T23:50:31.000Z - 5 months ago

CDT Equity Inc trading halted, news pending

2026-03-26T13:17:06.000Z - 5 months ago

CDT Equity expands Tapinarof intellectual property portfolio with patent filings

Mar 26, 2026, 8:30 AM EDT - 5 months ago

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

2026-03-25T12:27:39.000Z - 5 months ago

CDT Equity announces 1-for-25 reverse stock split

Mar 23, 2026, 8:30 AM EDT - 5 months ago

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

2026-03-18T12:46:14.000Z - 5 months ago

CDT Equity announces stockholders approved all proposals at Special Meeting

Mar 18, 2026, 8:30 AM EDT - 5 months ago

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

2026-03-12T12:36:57.000Z - 5 months ago

CDT Equity notes Sarborg expansion into rare disease signature intelligence

Mar 12, 2026, 8:30 AM EDT - 5 months ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

2026-03-05T13:47:10.000Z - 5 months ago

CDT Equity notes Sarborg filing of U.S. provisional patent application

Mar 5, 2026, 8:30 AM EST - 5 months ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

2026-03-04T13:38:28.000Z - 5 months ago

CDT Equity says advancing multiple initiatives to enhance shareholder value

AZN

Mar 4, 2026, 8:30 AM EST - 5 months ago

CDT Positions for Transformational Growth

Feb 24, 2026, 8:30 AM EST - 6 months ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

Feb 20, 2026, 8:30 AM EST - 6 months ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 8 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 10 months ago

CDT Equity Increases Bitcoin Holding

Sep 17, 2025, 8:30 AM EDT - 1 year ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 1 year ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

ka1954 Aug. 19 at 11:22 AM

$CDT another fucking stock that recently did RS went up 1000% PFSA, just like VEEE, WETO, NVVE. come on CDT, do something

0 · Reply

Sam201 Aug. 18 at 3:25 PM

$CDT getting back below 3. Easy swings above n below 3s. but this is riskyy

0 · Reply

Nevilhch Aug. 18 at 1:44 PM

$CDT @Sam201 and @Bears2354 Alright, you assholes, I don't see you promoting anything .Did you blow your accounts already?

0 · Reply

Nevilhch Aug. 18 at 12:16 PM

$CDT very soon 🤑🤑🤑

0 · Reply

ka1954 Aug. 17 at 8:17 PM

$CDT they will fuck this stock badly in coming days. it always happens

0 · Reply

JimmyOcarri Aug. 17 at 7:49 PM

$ICCM $AIIO $CDT $RBNE $FABC goodness

0 · Reply

Pennytraderr1 Aug. 17 at 7:05 PM

0 · Reply

ka1954 Aug. 14 at 1:56 PM

$CDT they do up 1 day to lure more buyers. no volume

0 · Reply

BigGreenCandle Aug. 13 at 7:04 PM

$CDT Vapor thin float. Has to go sometime. Moon or bust.

1 · Reply

ka1954 Aug. 13 at 11:16 AM

$CDT with the OS count of 786k, this should be flying 200%+, what a turd

0 · Reply

Bullish_Bearish88 Aug. 12 at 3:17 PM

$CDT always short this trash, More R/S and share dumps coming

0 · Reply

Nevilhch Aug. 12 at 2:14 PM

$CDT Have those cockroaches promoting this garbage stopped showing up? How are their finances doing? How much do your losses amount to now?jajaj short it

0 · Reply

Bullish_Bearish88 Aug. 12 at 1:10 PM

$CDT

0 · Reply

ka1954 Aug. 11 at 8:03 PM

$CDT next trend down has started

0 · Reply

DORO879 Aug. 11 at 7:37 PM

$LGHL $CPOP $RITR $LIMN $CDT

0 · Reply

Nevilhch Aug. 11 at 3:01 PM

$CDT That’s exactly what I’m telling you, brother. Keep listening to the promoters of this crap, and they’ll drive you to ruin. I’m going to stay short on this scam of a stock until the bitter end

0 · Reply

falcon630 Aug. 11 at 1:49 PM

$CDT looks like they are planning to dilute it back under a buck since the special meeting/vote next week is another rs thrown in with some other housekeeping issues. what a piece of crap.

0 · Reply

ka1954 Aug. 10 at 3:12 PM

$CDT that was it ?

1 · Reply

BigGreenCandle Aug. 7 at 4:06 PM

$CDT Moon potential.

1 · Reply

falcon630 Aug. 7 at 3:16 PM

$CDT have your sells ready

0 · Reply

Bears2354 Aug. 7 at 3:14 PM

$CDT up we go once we break the ceiling we are going hard 1 time ! 1 time that's all

0 · Reply

DORO879 Aug. 6 at 10:22 PM

If $RITR could jump 506% in one session, what could $LGHL do? Especially since it already gained 300% in a single day on July 14th. I always miss the boat even when I wait a long time like with $CDT it ends up doing a reverse split and I’m screwed. I’m just bad luck personified.

2 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A